Bio-Rad Laboratories, Inc. (Bio-Rad), manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. Bio-Rad operates in two segments: Life Science and Clinical Diagnostics.. As of December 31, 2011, the Company had direct distribution channels in over 35 countries outside the United States through subsidiaries. In January 2013, the Company purchased AbD Serotec, a division of MorphoSys AG. In April 2014, Bio-Rad Laboratories Inc purchased GnuBIO, Inc.